Ajax-Loading

Sumitomo Dainippon Pharma Co Ltd - Net Receivables

Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Net-Receivables" stands at 127.26 Billion Japanese Yens as of 09/30/2025, the highest value since 06/30/2022.

As of the end of Sumitomo Dainippon Pharma Co Ltd's second quarter, the item "Net Receivables" stands at 127.26 Billion JPY. This represents an increase of 47.76 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 84.74 percent compared to the value the year prior.
The 1 year change in percent is 84.74.
The 3 year change in percent is 10,058.60.
The 5 year change in percent is 9,152.16.
The 10 year change in percent is -36.08.

The Serie's long term average value is 98.28 Billion Japanese Yens. It's latest available value, on 09/30/2025, is 29.49 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2024, to it's latest available value, on 09/30/2025, is +22,523.49%.
The Serie's change in percent from it's maximum value, on 03/31/2016, to it's latest available value, on 09/30/2025, is -42.04%.

Net Receivables for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Net Receivables905,699,262,464.00
LogoJohnson & Johnson - Net Receivables486,508,953,600.00
LogoAbbVie Inc - Net Receivables399,570,305,024.00
LogoRoche Holding AG - Net Receivables317,433,206,677.55
LogoAstraZeneca PLC - Net Receivables280,205,508,085.11